CA

Charles Y Fiakpui


Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Edmonton, CA (1993 - 1999)
  • Alberta, CA (1995 - 2005)

Company Filing History:


Years Active: 1993-2005

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles Y Fiakpui

Introduction

Charles Y Fiakpui is a notable inventor based in California, recognized for his significant contributions to the field of antibacterial agents. With a total of 6 patents, his work has advanced the understanding and treatment of infections caused by gram-negative pathogenic bacteria.

Latest Patents

Among his latest patents is the invention of 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents. This invention relates to novel Syn isomers of racemates and optical isomers of 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids, which are utilized in treating infections caused by gram-negative pathogenic bacteria. Another significant patent involves 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives, showcasing his innovative approach to developing new antibacterial compounds.

Career Highlights

Throughout his career, Charles has worked with prominent companies such as Synphar Laboratories, Inc. and Taiho Pharmaceutical Company Limited. His experience in these organizations has allowed him to collaborate on various projects that have contributed to advancements in pharmaceutical sciences.

Collaborations

Charles has collaborated with esteemed colleagues, including Samarendra N Maiti and Ronald G Micetich. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.

Conclusion

Charles Y Fiakpui's innovative work in the field of antibacterial agents has made a significant impact on medical science. His patents and collaborations reflect his dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…